韩国胃癌临床实践指南2024:基于证据的多学科方法(2022版指南更新)
该指南为韩国胃癌实践指南第5版(2022年第4版更新),由多学科团队基于MEDLINE、Embase、Cochrane Library和KoreaMed系统综述更新6个关键问题并形成7条声明,采用GRADE系统分级证据与推荐,重点更新全身治疗领域并纳入近期研究结果。
要点
- 指南覆盖胃癌筛查、内镜、病理、影像和核医学诊断与分期等一般性内容。
- 6个关键问题经系统综述后更新或新提出,共形成或修订或讨论7条声明。
- 证据等级与推荐强度按GRADE系统分级,推荐考虑证据水平、获益、危害和临床适用性。
核心结论
- 该多学科、基于证据的胃癌指南旨在支持临床医生为胃癌患者提供最佳诊疗。
研究设计与样本
- 韩国胃癌实践指南第5版,为2022年第4版更新;由胃癌外科、消化内科、内镜、肿瘤内科、腹部放射学、病理学、核医学、放射肿瘤学和指南制定方法学专家组成的跨学科团队协作完成;基于MEDLINE、Embase、Cochrane Library和KoreaMed数据库系统综述更新或提出6个关键问题并形成7条声明;证据等级与推荐强度按GRADE系统分级。
诊断标准与关键数值
- 证据等级与推荐强度按GRADE系统分级,推荐关键因素包括证据水平、获益、危害和临床适用性。
- 前部分涵盖筛查、诊断及内镜、病理、放射学、核医学分期等一般性内容。
- 后部分按各关键问题基于临床证据提供声明,并以Meta分析和参考文献支持的流程图辅助。
临床应用与阅片要点
- 前部分一般性内容涵盖筛查、诊断及内镜、病理、放射学、核医学分期,可供影像阅片与报告参考。
- 后部分按关键问题提供基于临床证据的声明及支持流程图,工作组经讨论达成共识。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Gastric cancer is one of the most common cancers in both Korea and worldwide. Since 2004, the Korean Practice Guidelines for Gastric Cancer have been regularly updated, with the 4th edition published in 2022. The 4th edition was the result of a collaborative work by an interdisciplinary team, including experts in gastric surgery, gastroenterology, endoscopy, medical oncology, abdominal radiology, pathology, nuclear medicine, radiation oncology, and guideline development methodology. The current guideline is the 5th version, an updated version of the 4th edition. In this guideline, 6 key questions (KQs) were updated or proposed after a collaborative review by the working group, and 7 statements were developed, or revised, or discussed based on a systematic review using the MEDLINE, Embase, Cochrane Library, and KoreaMed database. Over the past 2 years, there have been significant changes in systemic treatment, leading to major updates and revisions focused on this area. Additionally, minor modifications have been made in other sections, incorporating recent research findings. The level of evidence and grading of recommendations were categorized according to the Grading of Recommendations, Assessment, Development and Evaluation system. Key factors for recommendation included the level of evidence, benefit, harm, and clinical applicability. The working group reviewed and discussed the recommendations to reach a consensus. The structure of this guideline remains similar to the 2022 version. Earlier sections cover general considerations, such as screening, diagnosis, and staging of endoscopy, pathology, radiology, and nuclear medicine. In the latter sections, statements are provided for each KQ based on clinical evidence, with flowcharts supporting these statements through meta-analysis and references. This multidisciplinary, evidence-based gastric cancer guideline aims to support clinicians in providing optimal care for gastric cancer patients.
引用
- Kim IH, Kang SJ, Choi W, et al. Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline). J Gastric Cancer. 2025. PMID: 39822170. doi:10.5230/jgc.2025.25.e11
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。